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The role of tRNA in translating the genetic code has received considerable attention over the last 50
years, and we now know in great detail how particular amino acids are speciﬁcally selected and
brought to the ribosome in response to the corresponding mRNA codon. Over the same period, it
has also become increasingly clear that the ribosome is not the only destination to which tRNAs deli-
ver amino acids, with processes ranging from lipid modiﬁcation to antibiotic biosynthesis all using
aminoacyl-tRNAs as substrates. Here we review examples of alternative functions for tRNA beyond
translation, which together suggest that the role of tRNA is to deliver amino acids for a variety of
processes that includes, but is not limited to, protein synthesis.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.Gln Asn1. tRNA-dependent amino acid biosynthesis
The attachment of amino acids to the 30-end of tRNAs is cata-
lyzed by the aminoacyl-tRNA synthetase (aaRS) family of proteins
[1]. aaRSs are ubiquitous and essential but only eukaryotes and a
handful of bacteria have the full set of 20 enzymes, one for each
canonical amino acid in the genetic code. Most bacteria and ar-
chaea lack asparaginyl-tRNA synthetase (AsnRS) and/or glutami-
nyl-tRNA synthetase (GlnRS) and some methanogenic archaea
lack cysteinyl-tRNA synthetase (CysRS) [2]. Also, no aaRS for the
rare amino acid selenocysteine has been found in any domain of
life [3]. These organisms instead use indirect pathways to synthe-
size a number of amino acids (Asn, Cys, Gln and Sec) directly on
their cognate tRNA: non-discriminating aaRSs ﬁrst form misacylat-
ed aminoacyl-tRNA (aa-tRNA), which is not used by the ribosome
but instead converted to cognate aa-tRNA by various RNA-depen-
dent modifying enzymes [4].
In organisms lacking GlnRS and AsnRS, Glu-tRNAGln and Asp-
tRNAAsn are synthesized by non-discriminating aaRSs and con-chemical Societies. Published by E
f Microbiology, Ohio State
210-1292, USA. Fax: +1 614verted to cognate Gln-tRNA and Asn-tRNA by tRNA-depen-
dent amidotransferases (AdT). Two types of AdT exist, the
heterotrimeric GatCAB present in both bacteria and archaea and
the homodimeric GatDE present in archaea [5,6]. The tRNA moiety
is recognized by the B and E kinase subunits of GatCAB and GatDE,
respectively, which phosphorylate the mischarged tRNAs to form
activated intermediates [7–9]. The glutaminase subunit (GatA/D)
liberates ammonia from an amide donor and amidates Glu or
Asp on the tRNA to form Gln or Asn, respectively. In both types
of AdT, a 40 Å-long hydrophilic channel connects the glutaminase
and kinase subunits [9,10]. It has been proposed, but remains to
be proven, that ammonia liberated in the glutaminase active site
is transported through the channel via a series of protonations
and deprotonations to the kinase active site, and that binding of
mischarged tRNA is required for opening the channel. Another
open question concerns the precise in vivo mechanism by which
misacylated aa-tRNA species are stabilized and escape detection,
and subsequent delivery to the ribosome, by elongation factor Tu
(EF-Tu). EF-Tu has a comparatively weak afﬁnity for non-cognate
aa-tRNA in vitro [11], but can bind and utilize such species under
some circumstances in vivo when Adt is absent [12]. The presence
of AdT seems to be critical; in Thermus thermophilus a ternary
‘‘transamidosome” complex is formed with aspartyl-tRNA synthe-
tase and tRNAAsn, thereby channeling Asp- tRNAAsn directly to AdT
[13]. Whether such a complex between AdT, aaRS and tRNA alsolsevier B.V. All rights reserved.
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open question.
The formation of higher order complexes that facilitate sub-
strate channeling, as seen with AdT, is also observed for the indi-
rect synthesis of Cys-tRNACys in some archaea [14]. The ﬁrst step
of tRNA-dependent Cys biosynthesis is formation of O-phosphose-
ryl-tRNACys (Sep-tRNACys) by SepRS [15–18], which is then trans-
formed to Cys-tRNACys by Sep-tRNA:Cys-tRNA synthase (SepCysS)
in a pyridoxal phosphate (PLP)-dependent manner [15]. SepRS
and SepCysS form a binary complex that not only promotes forma-
tion of the product but also protects the intermediate Sep-tRNACys
from being captured by elongation factor and subsequently deliv-
ered to the ribosome [19]. The mechanisms by which the rare ami-
no acid selenocysteine is incorporated into proteins share some
similarities with the indirect Cys-tRNACys pathway, synthesis
occurring viamisaminoacylation of the unique tRNASec with serine
[3]. The structure of human O-phosphoseryl-tRNA:selenocysteinyl-
tRNA synthase (SepSecS) with tRNASec, phosphoserine and thio-
phosphate, a substrate analog of selenophostate, together with
in vivo and in vitro studies, revealed the mechanism of selenocys-
teine formation in eukaryotes and archaea and how it differs from
the well-characterized bacterial pathway [20–23]. In archaea and
eukaryotes, SepSecS catalyzes the elimination of phosphate from
O-phosphoseryl-tRNASec (Sep-tRNASec) forming an intermediate
that is attacked by selenophosphate and subsequent hydrolysis
yields selenocysteinyl-tRNASec [21,24]. Bacteria instead use water
as the leaving group in the ﬁrst step, a difference that could poten-
tially be exploited to develop new transition state analog inhibitors
that target Sec-tRNASec biosynthesis.
2. Proofreading and editing
The tRNA-dependent amino acid synthesis pathways described
above all generate cognate aa-tRNAs as ﬁnal products, which canFig. 1. Fate of mischarged tRNAs in protein synthesis: Misactivated amino acids can be e
fashion (pathways 1 and 2, respectively). Following transfer mischarged aa-tRNA can be e
editing factors such as YbaK and AlaXps can also hydrolyze mischarged aa-tRNAs (pathw
tRNAAsn via the transamidase reaction (tRNA-dependent amino acid biosynthesis, pathwthen form ternary complexes with EF-Tu (EF-1a in eukaryotes)
for use in ribosomal protein synthesis. In effect, the multiple steps
of these indirect pathways provide a series of biosynthetic check-
points that maintain the ﬁdelity of aa-tRNA synthesis. This is not
the case with direct aa-tRNA synthesis; many aaRSs have difﬁculty
in discriminating against near-cognate amino acids, necessitating
proofreading (‘‘editing”) to clear non-cognate aa-tRNAs. Editing
by aaRSs can occur before (pre-transfer) and/or after (post-trans-
fer) attachment of the non-cognate amino acid to tRNA, as ex-
plained below.
2.1. Pre-transfer editing
Pre-transfer editing occurs immediately following ATP-depen-
dent activation of a non-cognate amino acid, before it is transferred
to tRNA (Fig. 1). Pre-transfer editing can be either tRNA-dependent
or independent, and occurs via multiple pathways including selec-
tive release into solution, selective hydrolysis or cyclization of ami-
noacyl adenylate (aa-AMP) by the enzyme active site [25]. tRNA
independent pre-transfer editing has been elucidated in aaRSs that
either lack or require a separate post-transfer editing site for their
canonical function [26–28]. Recently a dormant pre-transfer editing
pathway was uncovered in an Escherichia coli leucyl-tRNA synthe-
tase mutant deﬁcient in post-transfer editing, underscoring the sig-
niﬁcance of redundancy of editing pathways in general [29,30]. Pre-
transfer editing is enhanced inmany aaRSs in the presence of a tRNA
cofactor, which aids in translocation of misactivated aa-AMP to a
distal editing site. For example, in isoleucyl-tRNA synthetase, hydro-
lysis of non-cognate Val-AMP is believed to occur through a confor-
mational change induceduponmisacylationof tRNA,which requires
one round of the post-transfer editing reaction prior to subsequent
pre-transfer editing [31]. However, in many other examples, the ex-
act nature of tRNA-dependent aa-AMP hydrolysis remains unclear
and the precise mechanisms are unknown.dited prior to their transfer to the tRNA either in a tRNA independent or dependent
dited in cis (pathway 3) or trans (pathway 4) by the aaRS editing site. Free-standing
ay 4). Mischarged Glu-tRNAGln or Asp-tRNAAsn are converted to Gln-tRNAGln or Asn-
ay 5).
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Following aminoacylation of tRNA with a non-cognate amino
acid, several aaRSs utilize a post-transfer editing mechanism to
hydrolyze mischarged aa-tRNAs and prevent amino acid misincor-
poration during translation. The mechanisms of hydrolyzing mis-
charged aa-tRNA are known for several post-transfer editing
aaRSs, and can occur either in cis or in trans (Fig. 1). An important
prerequisite for the post-tranfer editing reaction is movement of
the 30-CCA end of the mischarged tRNA from the aminoacylation
site into the editing site [25]. Structural studies of class I aaRS have
shown conformational changes in both the tRNA and enzyme be-
tween the aminoacylation and editing states, which suggests the
30-CCA end of the tRNA directly translocates between the active
and editing sites (Fig. 1 Pathway 3 [32–35]). In support of this
model, aa-tRNA release has been shown to be the rate limiting step
in aminoacylation for class I aaRSs, giving the 30-CCA time to move
between the sites before being released [36]. While direct translo-
cation of the tRNA 30-CCA end between the aminoacylation and
editing sites is also thought to occur for class II aaRSs, dynamics
of tRNA movement appear to be more complex. Initial evidence
for phenylalanyl-tRNA synthetase (PheRS) supported the direct
translocation model and further data has not refuted this. How-
ever, for both PheRS and alanyl-tRNA synthetase (AlaRS) low levels
of mischarged species can be detected under certain conditions
[37,38]. These mischarged species do not compromise translational
ﬁdelity; once Tyr-tRNAPhe is released from the active site, the
PheRS editing site can compete effectively with EF-Tu for the mis-
charged tRNA and rebinds and edits the non-cognate species (Fig. 1
Pathway 4 [38]). While PheRS appears to utilize both tRNA translo-
cation and rebinding after release, a translocation model is unlikely
in AlaRS. Biochemical and structural data have shown that in AlaRS
the activation site and editing site have independent tRNAAla bind-
ing capabilities and tRNA likely rebinds to the editing site after
aminoacylation [39,40]. As product release is not the rate limiting
step of aminoacylation for class II aaRSs the aa-tRNA is likely re-
leased following aminoacylation and then rebound at the editing
site [36].Fig. 2. Cellular biosynthetic pathways that utilize aa-tRNAs. Examples are provided inIn addition to the editing domains present in some aaRSs, sev-
eral freestanding editing factors homologous to class II editing do-
mains can be found in all three kingdoms of life. These factors act
in trans to clear mischarged aa-tRNAs (Fig. 1 Pathway 4 [25]).
Examples include D-Tyr-tRNATyr deacylases [41], AlaXps [42], and
YbaK [43]. In the speciﬁc case of tRNAPro, trans-editing by YbaK
constitutes an additional layer of quality control by prolyl-tRNA
synthetase (ProRS). ProRS insertion domain (INS) cis-edits mis-
charged Ala-tRNAPro [44] whereas YbaK in complex with ProRS
serves to trans-edit Cys-tRNAPro [45,46]. It is not known why edit-
ing functions have become associated with the aaRS in some in-
stances while in other cases the editing domains have remained
independent of the aaRS, although it may reﬂect the need to edit
a wider range of non-cognate species for particular tRNA
isoacceptors.
3. aa-tRNAs as markers of a cell’s health
Aminoacylation, editing, and tRNA-dependent amino acid bio-
synthesis all serve a common goal, to generate a cellular pool of
cognate aa-tRNA. Normally the majority of this aa-tRNA pool is
delivered to the ribosome for protein synthesis, although some
components of this pool also provide amino acids for other biosyn-
thetic pathways (Fig. 2; see Section 4 below). When the aa-tRNA
pool becomes unbalanced the cell responds in a number of ways.
For example, bacteria adjust their metabolism using mechanisms
such as the stringent response to attempt to restore a complete
and balanced pool of aa-tRNA. In eukaryotes the consequences of
altering the aa-tRNA pool are more complex. For example overex-
pression of RNA pol III gene products, such as ribosomal 5S RNA
and tRNA, and increased protein synthesis, are key characteristics
of a large variety of tumor cells. In particular, the recent ﬁnding
that increased expression of tRNAiMet is sufﬁcient to drive cell pro-
liferation and oncogenic transformation has implicated tRNAs in
tumorigenesis [47].
Absence of extracellular amino acids causes a starvation re-
sponse in cells leading to deactivation of one of the major factors
driving cell growth and proliferation in eukaryotes, the TOR pro-the red shaded box of pathways, that require mischarged aa-tRNAs as precursors.
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also been shown to result in accumulation of tRNAs in the nucleus
[49–51]. Macroautophagy, a major intracellular catabolic process
of eukaryotes, is highly induced during starvation and functions
mainly to provide sufﬁcient nutrients (amino acids, lipids, sugars
and nucleotides) and energy for the cells to survive a temporary
depletion of nutrients [52]. As cellular levels of amino acids are
re-established tRNAs are re-exported to the cytosol. The presence
of tRNAs and amino acids in the cytosol and reactivation of mTOR
restores global protein synthesis, cell growth and proliferation.
Concurrently, autophagic activity returns to its basal cellular levels.
Due to their almost insatiable capacity for growth and prolifera-
tion, cancer cells often deplete nutrients from their immediate sur-
roundings, yet they still grow. It is believed that the autophagic
process plays a major role in tumor progression, functioning as
an essential survival mechanism that provides the deprived tumor
cells with adequate nutrients and energy to sustain growth [53].
One important factor inﬂuencing a tumor cell’s ability to grow
and proliferate is the availability of sufﬁcient aa-tRNAs in the cyto-
sol. It is essential for tumor cells to have an adequate supply of aa-
tRNAs in the near vicinity of the translational machinery in order
to keep up with the high demand for newly synthesized proteins.
This leads to the intriguing hypothesis that in proliferating tumor
cells, despite nutrient limitation, fully aminoacylated tRNAs may
be localized in the cytosol with the autophagic pathway supplying
adequate amino acids to sustain robust protein synthesis.
If tRNAs are predominantly cytoplasmic in nutrient deprived tu-
mor cells could this directly reﬂect a more global defect in nucleo-
cytoplasmic trafﬁcking? It is well known that nucleocytoplasmic
shuttling of oncogenes and tumor suppressors is often disrupted
in tumor cells resulting in mislocalization and alteration of their
cellular activities. Defective nucleocytoplasmic trafﬁcking can be
highly advantageous for proliferating cells when transcription fac-
tors which function as tumor suppressors are mislocated to the
cytosol [54]. Dysfunctional expression of human XPO-T or yeast
Los1p, which speciﬁcally export newly synthesized tRNAs from
the nucleus, is known to disrupt trafﬁcking leading to nuclear
accumulation of tRNAs [55,56]. Recent studies suggest that nuclear
accumulation of tRNAs transduces a starvation signal within the
cell most likely by signaling the mTOR pathway and activating
autophagy (MPI, unpublished data). Whether these effects emerge
directly from nuclear accumulation of tRNA or due to down-regu-
lated protein synthesis remains to be resolved. Interestingly, DNA
damage also affects nuclear export of tRNA, leading to accumula-
tion of immature tRNAs and subsequent execution of G1 and cell
cycle progression [57]. Taken together, recent data clearly suggest
that subcellular localization of tRNA, and its aminoacylation state,
are critical determinants of cell growth and proliferation providing
potential new strategies for the development of anti-cancer
therapeutics.4. tRNA-dependent addition of amino acids
Beyond their essential roles in protein synthesis, several aa-
tRNAs are also used in other amino acid addition pathways
(Fig. 2). These reactions involve aa-tRNAs of different speciﬁcities
and several types of acceptor molecules such as membrane lipids,
peptidoglycan precursors, proteins and intermediates for the bio-
synthesis of antimicrobial molecules.
4.1. tRNA-dependent addition of amino acids to membrane lipids
Initially discovered in Staphylococcus aureus, lysylphophatidyl-
glycerol synthase (LysPGS) transfers lysine from Lys-tRNALys to
phosphatidylglycerol (PG) within the cytoplasmic membrane toform lysyl-phosphatidylglycerol (Lys-PG) [58]. LysPGS, encoded
by the gene mprF (multipeptide resistance factor), is composed of
a membrane domain consisting of several transmembrane alpha-
helices and a cytoplasmic domain containing the active site of
the enzyme [59]. aaPGS homologs are widespread among bacteria
and are also found in certain archaea of the Methanosarcina genus
[59,60]. tRNA mediated addition of amino acids to the membrane
is one of the multiple mechanisms that has evolved in bacteria to
remodel their cell wall as they adapt to changing environments
[61]. Addition of positively charged amino acids to the highly neg-
atively charged phospholipids of the membrane diminishes the
afﬁnity of the bacterial envelope for cationic molecules within
the growth environment. Thus, Lys-PG in the membrane is associ-
ated with a wide variety of resistance phenotypes against various
cationic antibacterial peptides (CAMs) and several other antimicro-
bial molecules (for review see ref. [60]). In addition, LysPGS has
been associated with the virulence of several pathogenic microor-
ganisms in cell line models [58,60], and in animal [62,63] or plant
models [64].
Additional aa-tRNA speciﬁcities have been recently discovered
in the aaPGS protein family. AlaPGS in Clostridium perfringens
[65] and in Pseudomonas aeruginosa [66], and more recently an
ArgPGS in E. faecium [59] have all been characterized. These new
modiﬁcations provide bacteria with an enhanced repertoire of ami-
no acids with which to modify phospholipids and to further adapt
their membrane to environmental cues. In spite of the lack of addi-
tion of a net positive charge to the membrane, the addition of Ala
not only provides P. aeruginosa with resistance to CAMs and beta-
lactams, but also to acidic and osmotic stress growth conditions
[66,67]. The nature of the different phenotypes linked to the addi-
tion of amino acids to lipid polar head groups illustrates that in
addition to changing the net charge of the membrane and the afﬁn-
ity of the membrane for CAMs, these modiﬁcations may also
change more general biochemical and permeability properties of
the cellular barrier.
AaPGSs and EF-Tu have comparable afﬁnities for aa-tRNA, sug-
gesting that canonical species can effectively supply amino acids
for both protein synthesis and lipid modiﬁcation (Fig. 3 [65]).
The speciﬁcity of aaPGSs for each moiety of aa-tRNAs (i.e., amino
acid and tRNA) is less stringent than observed for aaRSs. AlaPGS
and LysPGS from C. perfringens can efﬁciently catalyze PG modiﬁca-
tion with a broad selection of RNA (heterologous tRNAs, minihelic-
es) acylated with the cognate amino acid (i.e., Ala or Lys,
respectively) [65]. In addition, certain aaPGSs can process more
than one aa-tRNA species in vitro. For example, the aaPGS from
E. faecium is triple speciﬁc and modiﬁes PG with Arg-tRNAArg,
Lys-tRNALys and Ala-tRNAAla, and the LysPGS from Bacillus subtilis
is able to use Lys-tRNALys and Ala-tRNAAla as amino acid donors
[59]. The physiological signiﬁcance of these multiple-speciﬁcity
aaPGS activities remains an open question.
4.2. tRNA-dependent addition of amino acids to the amino-terminus of
proteins
Another protein family able to utilize a range of aa-tRNAs is the
aminoacyl-transferase (aa-transferase), which initiate recycling of
damaged or excess peptides via the N-end rule. Found in bacteria,
fungi and mammals, the N-end rule relates the identity of the N-
terminal residue of a protein to its in vivo half-life [68]. This path-
way relies on an aa-transferase to recognize a secondary destabi-
lizing residue at the N-terminus of a target peptide and utilize an
aminoacyl-tRNA to transfer a primary destabilizing amino acid to
the N-terminal residue, making the protein a target for the cellular
degradation machinery [68]. In prokaryotes, the aat-encoded leu-
cylphenylalanyl-transferase (L/FK,R-transferase) demonstrates
afﬁnity for the secondary destabilizing residues Lys and Arg and at-
Fig. 3. Partitioning of Lys-tRNALys between protein synthesis and lipid remodeling. Lys-tRNALys shows comparable afﬁnities for LysPGS and EF-Tu, allowing aa-tRNAs to
potentially enter different biosynthetic pathways simultaneously.
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[70]. The presence of the primary destabilizing residue marks the
peptide as a target for ClpS, which transfers the protein to the
ClpAP machinery where it is degraded [68]. In eukaryotes, this
hierarchy differs with oxidized cystiene (Cys*), Asp, or Glu consti-
tuting secondary destabilizing residues that are attached to the pri-
mary destabilizing residue Arg by the ATE1-encoded
arginyltransferase (RC
 ,D,E-transferase) [71,72]. The primary desta-
bilizing residue marks the peptide as a target for ubiquitin conju-
gation and subsequent degradation by the eukaryotic proteasome
[68]. Recently, two aa-transferases that vary in speciﬁcity have
been discovered. ATEL1 arginyl-transferase (RD,E-transferase) in
the eukaryotic pathogen Plasmodium falciparum has sequence sim-
ilarity to the prokaryotic L/FK,R-transferase but the speciﬁcity of the
eukaryotic RD,E-transferase [73]. Bpt leucyl-transferase (L-D,E-
transferase), found in the prokaryotic human pathogen Vibrio vul-
niﬁcus, exhibits hybrid speciﬁcity conjugating leucine to the
eukaryotic secondary destabilizing residues of Asp and Glu [71].
Recently, the structure of E. coli L/FK,R-transferase has been
determined in complex with Leu-tRNALeu and an amino-terminal
Arg protein substrate [74–76]. This structure not only allowed fur-
ther veriﬁcation of the substrate binding sites but also the elucida-
tion of the catalytic mechanism, which previously remained
unknown. L/FK,R-transferase is a monomer consisting of two do-
mains [76]. The N-terminal domain adopts a novel fold while the
C-terminal domain resembles the GCN5-related N-acetyltransfer-
ase (GNAT) family [76]. Conserved residues lie along the central
cleft that exists at the interface of the two domains. At the bottom
of the cleft a deep hydrophobic pocket recognizes the side chain of
the bound tRNA while the backbone of the 3’-region of a tRNA-
acceptor helix is recognized by a cluster of highly conserved posi-
tively charged resides [75]. The hydrophobic nature of the pocket
selects for hydrophobic side chains while the size allows for the
selection of amino acid residues lacking a branched b-carbon
[74,75]. Recognition of primary substrate Leu-tRNALeu or the alter-
nate substrate Phe-tRNAPhe occurs in this manner. The main mode
of L/FK,R-transferase protein acceptor recognition is the presence of
an N-terminal basic amino acid residue [74]. This recognition is
achieved by the highly negatively charged surface area adjacent
to the binding site of the Arg or Lys side chain within the hydro-
phobic pocket [74]. Peptide-bond formation by L/FK,R-transferase
involves a protein-based reaction via an electron relay from a do-
nor Asp 186 residue to acceptor Gln 188 [74]. This mechanism
most closely resembles the reverse-acylation step of proteolysisby serine proteases and is distinct from ribosomal peptide-bond
formation.
Although there is currently no structure or mechanism for the
eukaryotic RC*,D,E-transferase, the roles it plays in cellular develop-
ment are well studied. Previously implicated in cardiovascular
development, the ﬁdelity of chromosome segregation, and the con-
trol of signaling by nitric oxide, RC*,D,E-transferase has also recently
been linked to leaf senescence and leaf and shoot development in
plants [69,72,77–80]. These effects seem to be the result of varying
expression levels of different isoforms with different protein tar-
gets in tissues [72,81]. Representative crystal structures of the dif-
ferent isoforms are needed to determine the speciﬁcity
determinants of protein acceptor recognition, as substrate recogni-
tion by prokaryotic L/FK,R-transferase seems to be sequence-inde-
pendent. Additional speciﬁc in vivo targets of prokaryotic L/FK,R-
transferase have yet to be determined. The only characterized tar-
get, PATase, implicates L/FK,R-transferase in putrescine homeosta-
sis as well as in increased speciﬁcity for the modiﬁcation of an
N-terminal methionine residue [82]. The recently discovered dual
aa-transferases, L/FK,R-transferase and LD,E-transferase, in the pro-
karyotic pathogen V. vulniﬁcus provide intriguing targets for the
identiﬁcation of additional potential in vivo targets.
4.3. tRNA-dependent addition of aa of to peptidoglycan precursors
Similar in structure, but not speciﬁcity or function to the amin-
oacyltransferases are a group of peptidyltransferases required for
peptidoglycan biosynthesis. First discovered in S. aureus [83], fac-
tors essential for methicillin resistance (Fem) are a type of non-
ribosomal peptidyltransferase that aid in cell wall biosynthesis
by extending the interpeptide bridge of the peptidoglycan mole-
cule [84,85]. The cross linking of short intrastrand peptides pro-
vides the cell with additional rigidity allowing for resistance to
b-lactam antibiotics, including methicillin. This process requires
not only FemABX enzymes, but also a selection of amino acids do-
nated by their corresponding tRNA isoacceptors [86]. To build the
interpeptide chain, the amino acid is activated and transferred to
its tRNA by an aaRS and then moved to a hexapeptide lipid inter-
mediate. FemABX catalyzes the addition of the amino acid to build
the interpeptide bridge. The type and number of residues consti-
tuting this chain varies by species, as do enzyme and substrate
speciﬁcities [87]. For example, S. aureus exhibits a pentaglycine
interpeptide chain and the three Fem proteins act individually to
link amino acids: FemX attaches the ﬁrst glycine residue to the e
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dues, and FemB links the ﬁnal two residues [84]. Following the for-
mation of the interpeptide chain, D,D-transpeptidases ﬁnalize the
cross linking of strands. This step is required, as incomplete or
incorrect formation of the interpeptide bridge leads to increased
antibiotic susceptibility or cell death [87].
In order for particular aa-tRNAs to be available for peptidoglycan
biosynthesis, theymust escape the protein biosynthesis machinery.
Some aa-tRNA isoacceptors sequestered for peptidoglycan biosyn-
thesis cannot complexwith EF-Tu:GTP due to the absence of certain
GTWC and GG sequences, and therefore are unable to bind to the
ribosome [86]. Recent studies involving chemical acylation of
RNA helicies [88] and site-directed mutagenesis [89] in Weissella
viridescens FemXwv have indicated some of the modes of recogni-
tion of aa-tRNA by FemX. The FemXwv active site excludes all amino
acids, with the exception of Gly and Ala, based on steric hindrance.
The enzyme then safeguards against misincorporation of Gly by
identifying the discriminator base of the tRNAGly and tRNAAla accep-
tor stems and binds tRNAAla, but not tRNAGly [88].
Along with the sequences of the aa-tRNAs, the structures of the
Fem proteins also dictate how they catalyze the transfer of amino
acid residues. The X-ray structure of S. aureus FemA was the ﬁrst of
the Fem family to be solved and it was found to include several
known protein folds that facilitate both peptide and aa-tRNA bind-
ing [85]. Fem A is composed of two domains: a globular domain,
which is divided into subdomains, 1A and 1B, and a domain con-
sisting of two helical arms. An L-shaped cavity in domain 1B serves
as FemA’s lone binding pocket and accommodates hexapeptide li-
pid intermediate binding. Similar to bacterial seryl-tRNA syntheta-
ses, the antiparallel coiled-coil structure of domain 2 docks aa-
tRNA as glycine is added to the growing pentaglycine chain [85].
As more is discovered about the speciﬁcities of the FemABX family,
as well as the isoacceptor tRNAs they utilize, they are also becom-
ing attractive targets for the development of antibiotics that specif-
ically target b-lactam resistant bacteria [89,90].
4.4. tRNA and antibiotic biosynthesis
The involvement of aa-tRNA in antibiotic biosynthesis provides
another role for this versatile molecule, particularly in diverse
environmental microorganisms such as Streptomyces, the soil-
dwelling multicellular bacteria that produce a myriad of bioactive
metabolites. Biosynthesis of complex antibiotics from simple met-
abolic precursors involves tens to hundreds of cellular factors that
are mostly encoded by horizontally acquired genes in biosynthetic
clusters. These species-speciﬁc activities of secondary metabolism
display substantial cross talk with the more conserved network of
primary metabolism that determines the onset and supports the
process of antibiotic production. tRNAs are required both for the
canonical biosynthesis of ribosomal peptide antibiotics [91] and
as regulators or alternative carrier molecules for non-ribosomal
antibiotic synthesis.
Genetic analysis of a mutant (bldA) of Streptomyces coelicolor
A3(2) implicated a tRNA speciﬁc for the leucine codon UUA – the
rarest codon in all Streptomyces genes – in antibiotic biosynthesis
and morphological development [91–93]. Deletion of the bldA gene
resulted in loss of two bioactive pigments, actinorhodin and unde-
cylprodigiosin, produced by S. coelicolor [94]. The bldA tRNA was
accumulated only when the antibiotics started to be produced,
which implied that the levels of charged tRNA might determine
the level of the products of TTA-containing genes in an adaptive
manner [94]. It was found that TTA codon-containing pathway-
speciﬁc regulatory genes are required for the expression of the bio-
synthetic genes in the two gene clusters [95]. Recently, bioinfor-
matic analyses with four Streptomyces genomes showed that the
majority of TTA-containing genes are species speciﬁc and relativelyrecently acquired [96]. Nearly half of the pathway-speciﬁc regula-
tory genes in the genomes analyzed contain TTA codons, suggest-
ing a way of limiting the biosynthesis of antibiotic in the host to
physiologically appropriate circumstances. Using rare codon tRNAs
to control antibiotic biosynthesis in Streptomyces could be a gen-
eral mechanism due to the uniqueness of the genomic contexts.
The developmentally regulated use of rare codon tRNAs is not lim-
ited to antibiotic biosynthesis. Rare tRNAs are also important for
bioﬁlm formation and dispersal in E. coli, and it seems likely that
still other roles remain to be discovered [97].
Recently the foundation has been laid for exploring additional
roles for tRNA in Streptomyces by the discovery of two biosynthetic
enzymes that can use aminoacyl-tRNAs. The antibiotic valanimycin
produced by Streptomcyes viridifaciens is derived from L-valine and
L-serine. L-valine is ﬁrst transformed to isobutylhydroxylamine
thatmust be reacted with L-serine during valanimycin biosynthesis
[98]. A seryl-tRNA synthetase gene unexpectedly identiﬁed in the
valanimycin biosynthetic gene cluster (vlm) gave rise to the idea
that the seryl residue could be transferred from seryl-tRNA to the
hydroxyl group of isobutylhydroxylamine [99]. When the VlmA
protein, which is distantly related to enzymes involved in the pep-
tidyl modiﬁcation of bacterial cell wall, was tested in an in vitro
reaction with the two substrates, O-seryl-isobutylhydroxylamine
was indeed formed and the formation was shown to be seryl-
tRNA-dependent. Another tRNA-dependent example is the biosyn-
thesis of albonoursin (alb) in Streptomyces noursei [100]. Albonour-
sin is a cyclodipeptide antibiotic made from L-phenylalanine and L-
leucine. A novel enzyme AlbC identiﬁed from the analysis of the alb
gene cluster was shown to catalyze the formation of two peptide
bonds at the same time to render the cyclic product. This reaction
only occurredwhen soluble extracts of E. coli cells, but not free ami-
no acids, were present. It was subsequently found that charged
E. coli tRNAPhe and tRNALeu were the required substrates. AlbC
homologs were identiﬁed in several other organisms including ﬁr-
micutes, actinobacteria and c-proteobacteria, all of which produced
cyclo(Tyr-Tyr) or cyclo(Leu-Leu) in the presence of ATP, the corre-
sponding amino acids and E. coli cell extracts. Treatment of the ex-
tracts with RNases abolished the formation of cyclopeptide,
strongly indicating a dependency on aminoacyl-tRNAs for synthe-
sis. Furthermore, numerous cyclodipeptides with the incorporation
of L-alanine, L-valine and L-methionine were detected, indicating
that AlbC and its homologs could use other tRNAs as substrates be-
sides tRNAPhe, tRNALeu and tRNATyr. These examples clearly demon-
strate that tRNA likely has many more roles that remain to be
uncovered by studying the dazzling variety of biochemical reac-
tions found in antibiotic biosynthetic pathways. In particular, bio-
chemical characterization of Streptomyces tRNAs may hold the
promise to discovering new antibiotic biosyntheses [101].5. tRNAs that do not function as aa-tRNA
While many roles of tRNA outside translation take advantage of
its capacity to carry activated amino acids, several important func-
tions do not require the aminoacyl form. Uncharged tRNAs func-
tion as sensors of amino acid concentration and as regulators of
global gene expression in response to changes in amino acid con-
centration. In Gram-positive bacteria, this regulation often occurs
via the T box transcription termination system in which an un-
charged tRNA binds to the 50 untranslated leader mRNA to induce
formation of an antiterminator over the competing intrinsic tran-
scriptional terminator [102]. Formation of the antiterminator al-
lows for continued transcription of the downstream genes, such
as those encoding the aaRSs and proteins involved in amino acid
biosynthesis and transport [102]. In response to amino acid starva-
tion in Gram-negative bacteria, such as E. coli, uncharged tRNAs
R. Banerjee et al. / FEBS Letters 584 (2010) 387–395 393stimulate the stringent response by inducing the production of the
global transcriptional regulator ppGpp, which regulates tRNA and
rRNA concentrations and genes involved in amino acid biosynthe-
sis [103]. Similarly, in certain eukaryotic cells under amino acid
starvation, uncharged tRNAs activate the protein Gcn2p, which re-
duces overall protein translation by phosphorylating eIF2 and in-
creases amino acid production by activating the transcriptional
regulator Gcn4p [104].
Uncharged tRNAs are often cleaved in half in response to amino
acid starvation to rapidly reduce tRNA levels, thereby reducing
protein translation [105,106,107]. However, tRNA cleavage is
developmentally regulated and not induced by amino acid starva-
tion in the Gram-positive bacterium S. coelicolor [108]. tRNA cleav-
age is also induced by oxidative stress in many eukaryotic cells,
including mammals and plants [108]. A recent study on Giardia
lamblia found that aa-tRNAs are cleaved in response to stress and
development to a dormant cyst [109]. Unlike cleaved uncharged
tRNAs, aa-tRNA cleavage products are retained at a constant level
throughout the stress response, and therefore may have functions
in addition to maintaining a low metabolic rate. It has been sug-
gested that uncharged tRNAs may act as regulators of gene expres-
sion, possibly as antisense RNAs. Uncharged tRNAs have also been
shown to act as primers for DNA synthesis of certain retrovirus
genomes and serve a regulatory role in replication of the ColE1
plasmid in E. coli by inducing cleavage of RNA I [110,111]. Further
exploration is now needed to more fully understand how tRNAs
and their cleavage products function as regulatory RNAs.
The function of a tRNA within translation can be predicted with
software programs that base tRNA prediction on the anticodon se-
quence, predicted secondary structure, and additional identity ele-
ments [112–114]. However, many of these annotated tRNA genes
lack canonical features, such as a predicted conserved secondary
structure, and are classiﬁed as pseudo-tRNAs [113,114]. These pseu-
do-tRNAsmay be relics of tRNAs that nowmaintain a different func-
tion, whether in biosynthesis of cell walls or antibiotics, regulation
of gene expression, or genome replication. One example is tRNA-
Other, a tRNA-like small RNA found in Bacillus cereus [115,116]. Dele-
tion of tRNAOther is not deleterious to growth, but causes the cell to
lose resistance to cationic antibiotics, ionophores, and detergents,
and alters transcript levels of one of two trpS genes during station-
ary phase. These unusual roles of tRNAOther suggest that other pseu-
do-tRNAs may also have unexpected functions outside translation.
6. Future prospects
The observation that binding to EF-Tu does not constitute an
irreversible commitment to protein synthesis [38] suggests that
aa-tRNAs might also provide a source of activated amino acids
for processes beyond those described above. In particular, the exis-
tence of aaRS paralogs in antibiotic synthesis gene clusters impli-
cates aa-tRNA as common precursors in antibiotic biosynthesis
[117]. Possible roles for tRNAs and pseudo-tRNAs outside transla-
tion are also starting to emerge, for example as members of the
broader class of regulatory RNAs [118,119]. Overall, recent ad-
vances have expanded the functional repertoire of aa-tRNAs,
tRNAs, and pseudo-tRNAs, and it seems likely that many more
functions await discovery in the post-genomic era.
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